Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biocytogen Pharmaceuticals (Beijing). (2315.HK) Q3 2024 Earnings
2315.HK
28
Aug
Confirmed
Q4 2022
Q2 2023
Q1 2024
Q3 2024
-0.53
-0.4
-0.26
-0.13
Details
Expected EPS
-0.12875946144
Actual EPS
-0.13948941656000002
Surprise EPS
-0.01
Surprise Percent
+8.33%
Description
Biocytogen Pharmaceuticals (Beijing). (2315.HK) has reported earnings of -0.13948941656000002 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist